CLINICAL_TRIALS
trial_result
· 2022-01-18
Clinical Trial Update: A Study of Naldemedine in Participants Undergoing Surgeries That Include a Bowel Resection or Bowel Transection [Phase 2]
Summary
Phase 2 study of naldemedine in patients undergoing surgeries with bowel resection or transection was terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shionogi | Conditions: Postoperative Gastrointestinal Dysfunction | Phase 2 | Status: TERMINATED | Results posted: 2022-01-18